762 related articles for article (PubMed ID: 22392053)
1. IL-33/ST2 axis in inflammation and immunopathology.
Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
[TBL] [Abstract][Full Text] [Related]
2. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML
PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861
[TBL] [Abstract][Full Text] [Related]
3. ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma.
Jovanovic I; Radosavljevic G; Mitrovic M; Juranic VL; McKenzie AN; Arsenijevic N; Jonjic S; Lukic ML
Eur J Immunol; 2011 Jul; 41(7):1902-12. PubMed ID: 21484786
[TBL] [Abstract][Full Text] [Related]
4. IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.
Jiang HR; Milovanović M; Allan D; Niedbala W; Besnard AG; Fukada SY; Alves-Filho JC; Togbe D; Goodyear CS; Linington C; Xu D; Lukic ML; Liew FY
Eur J Immunol; 2012 Jul; 42(7):1804-14. PubMed ID: 22585447
[TBL] [Abstract][Full Text] [Related]
5. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
Hayakawa H; Hayakawa M; Kume A; Tominaga S
J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
[TBL] [Abstract][Full Text] [Related]
6. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
7. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.
Smithgall MD; Comeau MR; Yoon BR; Kaufman D; Armitage R; Smith DE
Int Immunol; 2008 Aug; 20(8):1019-30. PubMed ID: 18550585
[TBL] [Abstract][Full Text] [Related]
8. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
Sweet MJ; Leung BP; Kang D; Sogaard M; Schulz K; Trajkovic V; Campbell CC; Xu D; Liew FY
J Immunol; 2001 Jun; 166(11):6633-9. PubMed ID: 11359817
[TBL] [Abstract][Full Text] [Related]
9. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.
Demyanets S; Kaun C; Pentz R; Krychtiuk KA; Rauscher S; Pfaffenberger S; Zuckermann A; Aliabadi A; Gröger M; Maurer G; Huber K; Wojta J
J Mol Cell Cardiol; 2013 Jul; 60():16-26. PubMed ID: 23567618
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
11. Protective role of IL-33/ST2 axis in Con A-induced hepatitis.
Volarevic V; Mitrovic M; Milovanovic M; Zelen I; Nikolic I; Mitrovic S; Pejnovic N; Arsenijevic N; Lukic ML
J Hepatol; 2012 Jan; 56(1):26-33. PubMed ID: 21703183
[TBL] [Abstract][Full Text] [Related]
12. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
Zeng S; Wu J; Liu J; Qi F; Liu B
Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
[TBL] [Abstract][Full Text] [Related]
13. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.
Brint EK; Fitzgerald KA; Smith P; Coyle AJ; Gutierrez-Ramos JC; Fallon PG; O'Neill LA
J Biol Chem; 2002 Dec; 277(51):49205-11. PubMed ID: 12368275
[TBL] [Abstract][Full Text] [Related]
14. Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective.
Ryba-Stanisławowska M; Stanisławowski M; Myśliwska J
Autoimmunity; 2014 Sep; 47(6):361-71. PubMed ID: 24547981
[TBL] [Abstract][Full Text] [Related]
15. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.
Kamekura R; Kojima T; Takano K; Go M; Sawada N; Himi T
Clin Exp Allergy; 2012 Feb; 42(2):218-28. PubMed ID: 22233535
[TBL] [Abstract][Full Text] [Related]
16. A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
Lin J; Zhang L; Zhao G; Su Z; Deng R; Pflugfelder SC; Li DQ
PLoS One; 2013; 8(4):e60963. PubMed ID: 23585867
[TBL] [Abstract][Full Text] [Related]
17. The IL-33/ST2 axis: Role in health and disease.
De la Fuente M; MacDonald TT; Hermoso MA
Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-33 and its receptor in T cell-mediated autoimmune diseases.
Zhao Q; Chen G
Biomed Res Int; 2014; 2014():587376. PubMed ID: 25032216
[TBL] [Abstract][Full Text] [Related]
19. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
Front Immunol; 2020; 11():581445. PubMed ID: 33133101
[TBL] [Abstract][Full Text] [Related]
20. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.
Coyle AJ; Lloyd C; Tian J; Nguyen T; Erikkson C; Wang L; Ottoson P; Persson P; Delaney T; Lehar S; Lin S; Poisson L; Meisel C; Kamradt T; Bjerke T; Levinson D; Gutierrez-Ramos JC
J Exp Med; 1999 Oct; 190(7):895-902. PubMed ID: 10510079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
